AstraZeneca, Pfizer, GlaxoSmithKline: Emerging Markets Earnings Roundup (Part 2 of 2)

Restructuring and diversification was the theme of third quarter earnings calls, as both American and European Big Pharma companies continued to shift resources into emerging markets. As a recurring feature, PharmAsia News combs through quarterly earnings reports to bring together the earning season's Asia highlights. Part one covered analysis of Eli Lilly, J&J and Novartis.